Risk of hepatotoxicity in cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis of published data.
about
Severe steroid-resistant anti-PD1 T-cell checkpoint inhibitor-induced hepatotoxicity driven by biliary injury.Approach and management of checkpoint inhibitor-related immune hepatitis.Immune-related adverse events with immune checkpoint inhibitors in thoracic malignancies: focusing on non-small cell lung cancer patients.
P2860
Risk of hepatotoxicity in cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis of published data.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Risk of hepatotoxicity in canc ...... ta-analysis of published data.
@ast
Risk of hepatotoxicity in canc ...... ta-analysis of published data.
@en
type
label
Risk of hepatotoxicity in canc ...... ta-analysis of published data.
@ast
Risk of hepatotoxicity in canc ...... ta-analysis of published data.
@en
prefLabel
Risk of hepatotoxicity in canc ...... ta-analysis of published data.
@ast
Risk of hepatotoxicity in canc ...... ta-analysis of published data.
@en
P2860
P356
P1476
Risk of hepatotoxicity in canc ...... ta-analysis of published data.
@en
P2093
Minzhang Guo
P2860
P304
P356
10.1002/IJC.30678
P577
2017-03-06T00:00:00Z